Optimization of the treatment with beta-lactam antibiotics in critically ill patients—guidelines from the French Society of Pharmacology and Therapeutics (Société …

R Guilhaumou, S Benaboud, Y Bennis… - Critical Care, 2019 - Springer
Background Beta-lactam antibiotics (βLA) are the most commonly used antibiotics in the
intensive care unit (ICU). ICU patients present many pathophysiological features that cause …

Pharmacokinetics–pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients

RP Veiga, JA Paiva - Critical Care, 2018 - Springer
Antimicrobials are among the most important and commonly prescribed drugs in the
management of critically ill patients and beta-lactams are the most common antibiotic class …

Pharmacokinetic issues for antibiotics in the critically ill patient

JA Roberts, J Lipman - Critical care medicine, 2009 - journals.lww.com
Objective: To discuss the altered pharmacokinetic properties of selected antibiotics in
critically ill patients and to develop basic dose adjustment principles for this patient …

What antibiotic exposures are required to suppress the emergence of resistance for gram-negative bacteria? A systematic review

CD Sumi, AJ Heffernan, J Lipman, JA Roberts… - Clinical …, 2019 - Springer
Background The rates of antibiotic resistance in Gram-negative bacteria are increasing. One
method to minimize resistance emergence may be optimization of antibiotic dosing …

Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams

J Gonçalves-Pereira, P Póvoa - Critical Care, 2011 - Springer
Introduction Several reports have shown marked heterogeneity of antibiotic
pharmacokinetics (PK) in patients admitted to ICUs, which might potentially affect outcomes …

Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy

AP Zavascki, CG Carvalhaes, RC Picao… - Expert review of anti …, 2010 - Taylor & Francis
Pseudomonas aeruginosa and Acinetobacter baumannii are major nosocomial pathogens
worldwide. Both are intrinsically resistant to many drugs and are able to become resistant to …

The use of noncarbapenem β-lactams for the treatment of extended-spectrum β-lactamase infections

PD Tamma, J Rodriguez-Baňo - Clinical Infectious Diseases, 2017 - academic.oup.com
The continued rise in infections caused by extended-spectrum β-lactamase (ESBL)–
producing pathogens is recognized globally as one of the most pressing concerns facing the …

Clinical pharmacokinetics and pharmacodynamics of cefepime

GM Pais, J Chang, EF Barreto, G Stitt… - Clinical …, 2022 - Springer
Cefepime is a broad-spectrum fourth-generation cephalosporin with activity against Gram-
positive and Gram-negative pathogens. It is generally administered as an infusion over 30 …

A systematic review on clinical benefits of continuous administration of β-lactam antibiotics

JA Roberts, S Webb, D Paterson, KM Ho… - Critical care …, 2009 - journals.lww.com
Objective: The clinical benefits of extended infusion or continuous infusion of β-lactam
antibiotics remain controversial. We systematically reviewed the literature to determine …

Cefepime Therapy for Monomicrobial Bacteremia Caused by Cefepime-Susceptible Extended-Spectrum Beta-Lactamase–Producing Enterobacteriaceae: MIC …

NY Lee, CC Lee, WH Huang, KC Tsui… - Clinical infectious …, 2013 - academic.oup.com
Background. Extended-spectrum ß-lactamase (ESBL)–producing Enterobacteriaceae
isolates are important clinical pathogens. In addition, the efficacy of cefepime for such …